{
    "nctId": "NCT05663021",
    "briefTitle": "Feasibility in Identification of Breast Cancer Candidates for Elimination of Axillary Surgery",
    "officialTitle": "Feasibility in Identification of Suitable Candidates for Elimination of Axillary Surgery in Breast Cancer Patients With Initial Biopsy-confirmed Nodal Metastases",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 191,
    "primaryOutcomeMeasure": "Diagnostic Accuracy of Ultrasound-Guided Core Biopsy of Initial Breast Cancer Region Compared to Axillary Surgery with Pathologic Evaluation Cancer Region Compared to Standard Surgery with Pathologic Evaluation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Clinical stage T1-4 N1-3M0 breast cancer at diagnosis (prior to neoadjuvant chemotherapy) by American Joint Committee on Cancer (AJCC) staging 7th edition\n2. Aged above 18 and below 70 years\n3. No other malignancy within 5 years of registration with the exception of basal cell or squamous cell carcinoma of the skin treated with local resection only or carcinoma in situ of the cervix\n4. Patients must have had estrogen receptor, progesterone receptor and HER2 status (by immunohistochemistry \\[IHC\\] and/or in situ hybridization \\[ISH\\]) evaluated on core needle biopsy prior to starting neoadjuvant chemotherapy\n5. Completing all planned cycles and regimens of neoadjuvant chemotherapy followed by axillary surgery\n\nExclusion Criteria:\n\n1. Nonrepresentative core needle biopsy in the breast during neoadjuvant chemotherapy\n2. Inflammatory breast cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}